KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Research & Development: 2009-2014

Historic Research & Development for Biocryst Pharmaceuticals (BCRX) over the last 6 years, with Dec 2014 value amounting to $51.8 million.

  • Biocryst Pharmaceuticals' Research & Development rose 53.94% to $20.1 million in Q3 2015 from the same period last year, while for Sep 2015 it was $72.2 million, marking a year-over-year increase of 48.14%. This contributed to the annual value of $51.8 million for FY2014, which is 23.49% up from last year.
  • As of FY2014, Biocryst Pharmaceuticals' Research & Development stood at $51.8 million, which was up 23.49% from $41.9 million recorded in FY2013.
  • In the past 5 years, Biocryst Pharmaceuticals' Research & Development registered a high of $83.9 million during FY2010, and its lowest value of $41.9 million during FY2013.
  • In the last 3 years, Biocryst Pharmaceuticals' Research & Development had a median value of $49.2 million in 2012 and averaged $47.6 million.
  • In the last 5 years, Biocryst Pharmaceuticals' Research & Development tumbled by 32.18% in 2011 and then climbed by 23.49% in 2014.
  • Over the past 5 years, Biocryst Pharmaceuticals' Research & Development (Yearly) stood at $83.9 million in 2010, then plummeted by 32.18% to $56.9 million in 2011, then dropped by 13.60% to $49.2 million in 2012, then fell by 14.68% to $41.9 million in 2013, then increased by 23.49% to $51.8 million in 2014.